Member Info for Safy

Aframan

Can you give me one example where BAMS would be better than an equally accurate LFT?

This isn’t an endorsement to buy, not giving money advice. I just wanted to raise awareness that what the company achieved today was a huge milestone.

There is also some political bias when applying for fda. So again that further emphasises what the company achieved as being significant.

FDA approval is gold dust. Many a company have tanked on failure to secure approval or emergency approval being removed.

All countries across the world recognise FDA as a gold standard approval, to the best of my knowledge it’s also the most sought after approval in the world.

Motif Bio tanked on failure to get FDA
SONA tanked on failure to get FDA
There are lots more examples

The fact that this company has FDA is the reason I invested today, I didn’t even need to read the RNS before hitting the buy button.

Hopefully good days ahead for us. And I’m surprised it took until this afternoon to get going. This should have been SNG #2 today.

Reckoner

I apologise if I came across in a negative way, it’s just soo boring and predictable as we seem to be having this debate daily now.

This board is littered with Avacta posters who crawl out every other day trying to get ODX punters to buy Avacta shares.

Logic would say that if the Avacta punters are so sure ODX will make their tests then they should be the ones buying in here. ODX holders meanwhile are only focusing on Mologic. The evidence is there as MB has posted a million times, as ODX holders we want our own brand to succeed NOT dream about Avacta especially as they have no test. The core posters do not have Avacta as an opportunity here and I’m convinced they never will as long as Mologic don’t fail.

Just to give you a heads up, apparently Mologic have an antigen / antibody test rolled into one LFT. This should give doubters an idea how far ahead they are. Their antigen LFT has undergone trials in a live setting. Not just at Heathrow but at least one other gov provided testing station. At Heathrow they compared results against a gov approved PCR test. That’s really upping the ante. That was in August.

Mologic wouldn’t go into live trials with tests made with sticky tape, they mean business. Their CEO was recently quoted in the FT for this same LFT. Their most recent presentation from mid October has this test in the slide deck.

Reckoner

Everything I posted isn’t boohoo stuff mate.

The capacity stuff is posted by an Avacta holder, I can’t help it if they have said ‘potential’ in the press release.
The TT stuff I learned from an Avacta poster who tried to deramp here saying our Mologic TT would take 4 months because it’s taking Avacta 4 months, all this after CK said 4 weeks ish.
The BAMS test is as good as dead, the market for lab tests is reducing by the day.
I can’t help Avacta if there is no compelling evidence their test exists. If there was I would be the first to buy in there. I’ll also say that twice I’ve had holdings in AVCT in the past.

For the few that want to believe MB’s posts are researched and written well with evidence. Hope they help people who are unsure.

4 month blueprint, that’s IF it takes 4 months and assuming there is a test at the end of it LOL which at the moment isn’t known. And your burning through the placement 10m to cover BAM and LFT. Do you know PCR tests are gen1 and it’s now all about gen2 tests?

You guys are deramping your own share now PMSL

Buy in here tomorrow, far less risky than Avacta who don’t have a test and their BAMS is dead even before it came into the market... wait that’s not ready yet either is it?

I’ll give you an update, India didn’t go so well. We don’t lie about these things. It’s in the trading update.

Mologic were focussed on ‘saliva’ antigen Elisa too and even they’ve stopped developing that test in favour of LFT.

The world is moving fast. It’s all about LFT’s now.

Perhaps Avacta will finally concede that the BAMS test is dead now too but I don’t know why they RNS to say they’ve sent free tests to Joe in never land and holders still get excited.

I wish I could make a sticky of MB’s posts as a FAO Avacta holders who troll this board.

You guys are like a broken record, every poster is sick to death of it.

The margins are not huge on LFT’s, if you guys are soooooooo confident ODX will make your test then drop the ego and buy in here to maximise your profit. You know it makes sense. On the contrary nobody in ODX believes we will be making your test so we are happy where we are.

have you started the 4 month tech transfer to abi?

Doh

Your own Avacta friend posted this on this thread. Have you got selective reading problems?

The manufacturing agreement between BBI and Avacta comprises accelerated development and validation of a scaled-up manufacturing process that has the potential to ramp up to a production capacity of millions of tests per month. Avacta, Cytiva and BBI are in the process of technology transfer of the prototype and related manufacturing procedures for the saliva-based rapid COVID-19 antigen test from Cytiva to BBI.

Keyword....potential

Which Alistair? The one who sold shares recently?

Nice try mate.

MB

These tests are sub £5

Given the fact that Avacta have zero manufacturing capability it’ll be incredibly difficult for them to make any serious money, especially if they are late to market.

Manufacturers don’t change production lines on a whim, they’ll just make millions of the test they signed up for and optimise processes and save costs, there could also be things in the supply contracts to make the test components cheaper over time. As the margins are not too dissimilar between each test I just can’t see late comers making a big dent in demand.

Also BBI capacity isn’t huge, one of the links above states they’ll ramp up to millions a month. We are going to ramp up to millions too. And if bbi are the ONLY partner which I think they are. For the most in demand test in the world having a capacity which is in the hundreds of thousands right now..... I rest my case there my friend.

Avacta should have a queue X miles long for manufacturers wanting their test. Except they don’t and they’ve signed up to bbi who’s own capacity isn’t exactly huge. What does that tell you?

Trip

Merchant has answered the question. Anyway this is the ODX board, not a board for Avacta people to come to try and convince others there is a test at the end of your tunnel. You need to be telling Avacta people to BUY lots and lots of ODX shares if you are soo convinced ODX will be making your test.

We are already invested here, we dont need Avacta to tell us ODX is a good investment.

Most researched folk on ODX will absolutely not buy Avacta shares in the hope we may make your test, but logic tells me ALL Avacta people should be in ODX because they dont have any manufacturing capacity, especially as you say we will be making your tests.

Dodge, you clearly are NOT reading or still deramping.

"Mologic's own ppt states Oct CE mark. The presentation is from mid October.

I'm assuming they've failed their own deadline but my research tells me its due in early November. I could be wrong obviously and it could be later, but you have my assurance I have not made up this early November date."

Vascular

That article is from 10th August, its now November.

Vascular

Show me one article, picture, report of the Avacta test in a live trial.

Dodge,

You're not reading my message or perhaps your talking about something else now.

Mologic need to CE FIRST before TT can commence. And yes its approximately 4 weeks but not likely to be less.

wyndrum,

We just prefer real news and not fairy tales.
Mologic have a test, Avacta dont.

Mologics test will be rebranded to Omega's brand. So yes we prefer Mologic over Avacta, not only because we know Mologic have a test, but also because its got our name on it.

Dodge

Mologic's own ppt states Oct CE mark. The presentation is from mid October.

I'm assuming they've failed their own deadline but my research tells me its due in early November. I could be wrong obviously and it could be later, but you have my assurance I have not made up this early November date.

As far as the investment in ODX goes, once Mologic CE, we know the test is good to go and its game on from there.

Dodge

Mologic START of November.

Merchant

Definitely its not, cross ramping because as each day passes they know its not them, nor are they close to having a test.